Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA cross-links are covalent chemical bonds that form between two nucleotides in a DNA molecule, occurring either on the same strand (intrastand) or between opposing strands (interstrand cross-links or ICLs) (Source: PubMed PMC3100973). These lesions are highly cytotoxic because they prevent the DNA double helix from unwinding, thereby stalling essential cellular processes such as DNA replication and transcription (Source: Nature Reviews Molecular Cell Biology). In clinical oncology, DNA cross-linking is a validated therapeutic strategy; several classes of chemotherapy, including platinum-based agents and nitrogen mustards, exert their anti-tumor effects by inducing these lesions (Source: StatPearls). The resulting DNA damage triggers cell cycle arrest and apoptosis, particularly in rapidly proliferating malignant cells (Source: NCI Drug Dictionary). However, the efficacy of these drugs is often limited by cellular DNA repair mechanisms, such as the Fanconi anemia pathway and nucleotide excision repair, which can remove the cross-links and lead to chemoresistance (Source: Nature Reviews Cancer). Furthermore, because these agents are not site-specific, they can cause significant systemic toxicity and increase the risk of secondary cancers (Source: PubMed PMC4113511).
Induction of covalent linkages between DNA strands (interstrand) or within a single strand (intrastand), which physically prevents the separation of the DNA double helix, thereby blocking replication and transcription and inducing apoptosis (Source: StatPearls, PubMed PMC3100973).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA cross-link (ICL) (ICL).